Congenital presentation of synchronous Atypical Teratoid Rhabdoid Tumor and Malignant Rhabdoid Tumor of the urinary bladder in a term infant
Vivian Tang; Peter Michael Conner; Jason Paul Tovar; Regina Frances Gandour-Edwards; Reuben Antony; Matthew Bobinski; Michael Steven Brent Edwards; Mirna Lechpammer
Abstract
Keywords
References
1 Centers for Disease Control and Prevention (CDC). Birth to 24 months: Girls Weight-for-length percentiles and Head circumference-for-age percentiles. Atlanta: CDC; 2009 [cited 2020 Apr 19]. Available from:
2 Evetts AM, Shkrum MJ, Tugaleva E. A new reference source for postmortem body measurements and organ weights in neonates and infants: a statistical analysis based on sudden death classification (Part 2). Am J Forensic Med Pathol. 2018;39(4):285-303.
3 Molina DK, Pinneri K, Stash JA, Li L, Vance K, Cross C. Organ weight reference ranges for ages 0 to 12 Years. Am J Forensic Med Pathol. 2019;40(4):318-28.
4 Haas JE, Palmer NF, Weinberg AG, Beckwith JB. Ultrastructure of malignant rhabdoid tumor of the kidney. A distinctive renal tumor of children. Hum Pathol. 1981;12(7):646-57.
5 Tsuneyoshi M, Daimaru Y, Hashimoto H, Enjoji M. The existence of rhabdoid cells in specified soft tissue sarcomas. Histopathological, ultrastructural and immunohistochemical evidence. Virchows Arch A Pathol Anat Histopathol. 1987;411(6):509-14.
6 Rorke LB, Packer R, Biegel J. Central nervous system atypical teratoid/rhabdoid tumors of infancy and childhood. J Neurooncol. 1995;24(1):21-8.
7 Zangari A, Zaini J, Gulìa C. Genetics of bladder malignant tumors in childhood. Curr Genomics. 2016;17(1):14-32.
8 Ostrom QT, Chen YM, de Blank P, et al. The descriptive epidemiology of atypical teratoid/rhabdoid tumors in the United States, 2001-2010. Neuro-oncol. 2014;16(10):1392-9.
9 Biegel JA. Molecular genetics of atypical teratoid/rhabdoid tumor. Neurosurg Focus. 2006;20(1):E11.
10 Reddy AT, Strother DR, Judkins AR, et al. Efficacy of high-dose chemotherapy and three-dimensional conformal radiation for atypical teratoid/rhabdoid tumor: a report from the children’s oncology group trial ACNS0333. J Clin Oncol. 2020;38(11):1175-85.
11 Biegel JA, Zhou JY, Rorke LB, Stenstrom C, Wainwright LM, Fogelgren B. Germ-line and acquired mutations of INI1 in atypical teratoid and rhabdoid tumors. Cancer Res. 1999;59(1):74-9. PMid:9892189.
12 Versteege I, Sévenet N, Lange J, et al. Truncating mutations of hSNF5/INI1 in aggressive paediatric cancer. Nature. 1998;394(6689):203-6.
13 Louis DN, Ohgaki H, Wiestler OD, Cavenee WK. WHO classification of tumours of the central nervous system. 4th ed. Lyon: IARC; 2016.
14 Sredni ST, Tomita T. Rhabdoid tumor predisposition syndrome. Pediatr Dev Pathol. 2015;18(1):49-58.
15 Bourdeaut F, Lequin D, Brugières L, et al. Frequent hSNF5/INI1 germline mutations in patients with rhabdoid tumor. Clin Cancer Res. 2011;17(1):31-8.
16 Eaton KW, Tooke LS, Wainwright LM, Judkins AR, Biegel JA. Spectrum of
17 Hasselblatt M, Nagel I, Oyen F, et al.
Submitted date:
04/11/2020
Accepted date:
06/28/2020
Publication date:
11/20/2020